-+ 0.00%
-+ 0.00%
-+ 0.00%

BRIEF-Anavex Life Sciences Announces Continued Long-Term Benefit From Oral Blarcamesine In Alzheimer’s Disease

Reuters·10/29/2025 12:50:47

Please log in to view news